Champions Oncology Inc (CSBR):企業の財務・戦略的SWOT分析

◆英語タイトル:Champions Oncology Inc (CSBR) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH81642FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥68,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥102,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Champions Oncology Inc (Champions), formerly Champions Biotechnology Inc, is a developer of advanced technology solutions and services to personalize the development and use of oncology drugs. The company’s technology platform is an approach based upon the implantation of primary human tumors in immune-deficient mice followed by propagation of the resulting engraftments. It offers personalized tumorgraft development, drug studies and genome sequencing as part of personalized oncology solutions. Champions also provide translational oncology solutions to oncologists, pharmaceutical and biotechnology companies. The company has operations in the US and the UK. Champions is headquartered in Hackensack, New Jersey, the US.

Champions Oncology Inc Key Recent Developments

Feb 12,2021: Champions Oncology: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers
Jan 19,2021: Champions Oncology announces partnership with code ocean to expand the functionality of Lumin Bioinformatics
Jan 05,2021: Champions Oncology announces the expansion of Lumin Bioinformatics: Now featuring a highly valuable set of proteomic data and analytics

This comprehensive SWOT profile of Champions Oncology Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Champions Oncology Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Champions Oncology Inc – Key Information
Champions Oncology Inc – Overview
Champions Oncology Inc – Key Employees
Champions Oncology Inc – Key Employee Biographies
Champions Oncology Inc – Key Operational Heads
Champions Oncology Inc – Major Products and Services
Champions Oncology Inc – History
Champions Oncology Inc – Company Statement
Champions Oncology Inc – Locations And Subsidiaries
Champions Oncology Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Champions Oncology Inc – Business Description
Champions Oncology Inc – Corporate Strategy
Champions Oncology Inc – SWOT Analysis
SWOT Analysis – Overview
Champions Oncology Inc – Strengths
Champions Oncology Inc – Weaknesses
Champions Oncology Inc – Opportunities
Champions Oncology Inc – Threats
Champions Oncology Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Champions Oncology Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Champions Oncology Inc, Key Information
Champions Oncology Inc, Key Ratios
Champions Oncology Inc, Share Data
Champions Oncology Inc, Major Products and Services
Champions Oncology Inc, History
Champions Oncology Inc, Key Employees
Champions Oncology Inc, Key Employee Biographies
Champions Oncology Inc, Key Operational Heads
Champions Oncology Inc, Other Locations
Champions Oncology Inc, Subsidiaries
Champions Oncology Inc, Key Competitors
Champions Oncology Inc, SWOT Analysis
Champions Oncology Inc, Ratios based on current share price
Champions Oncology Inc, Annual Ratios
Champions Oncology Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Champions Oncology Inc (CSBR):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sykes Enterprises Inc (SYKE)
    Sykes Enterprises Inc (SYKE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Arena Pharmaceuticals Inc (ARNA)-製薬・医療分野:企業M&A・提携分析
    Summary Arena Pharmaceuticals Inc (Arena) is a biopharmaceutical company which discovers, develops and commercializes small molecule drugs in multiple therapy areas. Its pipeline portfolio encompasses etrasimod for multiple inflammatory indications; ralinepag for the treatment of pulmonary arterial …
  • Hangzhou Tigermed Consulting Co Ltd (300347):製薬・医療:M&Aディール及び事業提携情報
    Summary Hangzhou Tigermed Consulting Co Ltd (Hangzhou Tigermed) is a contract research organization that provides professional clinical trial services. The organization offers preclinical, clinical trials, registration and regulation; and other services. Its clinical trial services include monitorin …
  • Witte Molen NV:企業の戦略・SWOT・財務分析
    Witte Molen NV - Strategy, SWOT and Corporate Finance Report Summary Witte Molen NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Cosan S.A. Industria e Comercio (CSAN3):電力:M&Aディール及び事業提携情報
    Summary Cosan S.A. Industria e Comercio (Cosan), a subsidiary of Cosan Limited, is an integrated bioenergy company. It invests in diversified industries including agribusiness, fuel and natural gas distribution, and lubricants. The company distributes lubricants, fuel oil, and piped natural gas; and …
  • Endesa SA (ELE):電力:M&Aディール及び事業提携情報
    Summary Endesa SA (Endesa), a subsidiary of Enel SpA, is an electric utility. It generates, distributes, and sells electricity. The company produces electricity in hydro, thermal, nuclear, combined cycle, and renewable and cogeneration plants. Endesa also supplies electricity and gas, and provides o …
  • Development Bank of Southern Africa-エネルギー分野:企業M&A・提携分析
    Summary Development Bank of Southern Africa (DBSA) offers various leading and infrastructure development financial services. Its service offering includes debt limited non-recourse lending, mezzanine finance, and promotion of inter-regional integration and co-operation. It offers implementation serv …
  • Raytheon Co:戦略・SWOT・企業財務分析
    Raytheon Co - Strategy, SWOT and Corporate Finance Report Summary Raytheon Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Electronic Arts Inc.:企業の戦略・SWOT・財務分析
    Electronic Arts Inc. - Strategy, SWOT and Corporate Finance Report Summary Electronic Arts Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • HighPoint Resources Corp (BBG):企業の財務・戦略的SWOT分析
    Summary HighPoint Resources Corp (HighPoint Resources) formerly Bill Barrett Corp, is an oil and gas company that explores and produces crude oil and natural gas. The company develops and operates oil and natural gas assets located in the Denver-Julesburg Basin of Colorado. Its Denver-Julesburg Basi …
  • Ogeda SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Ogeda SA (Ogeda), formerly Euroscreen SA, a subsidiary of Astellas Pharma Inc, is a clinical-stage drug discovery company that invents and develops fezolinetant and small molecule drugs targeting G-protein coupled receptors. The company discovers and develops drugs that treat hormone-depende …
  • Jupiter Telecommunications Co Ltd:企業の戦略的SWOT分析
    Jupiter Telecommunications Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • NTN Corporation (6472):企業の財務・戦略的SWOT分析
    NTN Corporation (6472) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Fabasoft Ag:企業の戦略・SWOT・財務分析
    Fabasoft Ag - Strategy, SWOT and Corporate Finance Report Summary Fabasoft Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Aviakompaniya Sibir” OAO (P):企業の戦略・SWOT・財務分析
    Aviakompaniya Sibir'' OAO (P) - Strategy, SWOT and Corporate Finance Report Summary Aviakompaniya Sibir'' OAO (P) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Cathay Pacific Airways Limited:企業の戦略・SWOT・財務情報
    Cathay Pacific Airways Limited - Strategy, SWOT and Corporate Finance Report Summary Cathay Pacific Airways Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Sunoco LP (SUN):石油・ガス:M&Aディール及び事業提携情報
    Summary Sunoco LP (Sunoco), a master limited partnership company that sells motor fuels in retail and wholesale channels. It offers motor fuel under brands such as Sunoco, Citgo, Chevron, Conoco, Aloha, Exxon, Mahalo, Mobil, Phillips 66, Texaco, Shell, Shamrock and Valero. The company operates throu …
  • Enterome Bioscience SA-製薬・医療分野:企業M&A・提携分析
    Summary Enterome Bioscience SA (Enterome) is a drug development company that develops medical tests, and companion diagnostics to develop the management of microbiome-related diseases. The company develops medical tests based on its metagenotype technology platform that helps to identify microbiome- …
  • CRRC Corporation Limited:企業の戦略・SWOT・財務情報
    CRRC Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary CRRC Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Parex Resources Inc (PXT):石油・ガス:M&Aディール及び事業提携情報
    Summary Parex Resources Inc (Parex) is an oil and gas exploration and development company that acquires, explores, develops and produces crude oil and natural gas in South America and the Caribbean. The company holds interests in land base of 1.7 million gross acres over 22 blocks in Colombia's Llan …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆